Adaptive Pharmacotherapy for Smoking Cessation
A randomized, controlled trial of adaptive pharmacotherapy for smoking cessation shows quit rates nearly three times the standard treatment.
Do Telehealth Interventions for Substance Use Disorders Lead to Superior Results?
The COVID-19 pandemic sparked a new era in telehealth interventions for substance use disorders. New studies show it’s working out pretty well.
In Search of the Connection Between Depression and Addiction
Three different academic researchers examine the connection between depression and addiction.
Testing GLP-1 Drugs for Substance Use Disorders
Limited human trials of GLP-1 drugs for substance use disorders indicate they might not work well for non-obese individuals.
A New Book Makes The Case That Addiction Is Not a Brain Disease
A new book and a new brain study are raising doubts about addiction as a chronic brain condition.
Does Ozempic Cause Weight Loss By Making People Sick?
We examine anecdotal reports and scientific evidence concerning gastrointestinal discomfort as a result of taking GLP-1 drugs.